Afleveringen
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers the topic of grief with Dr. Cindy Grief, a Geriatric Psychiatrist at Baycrest Health Sciences in Toronto, where she is the Medical Director for Mental Health Services. She is also an Associate Professor at the University of Toronto and has played active roles in postgraduate and continuing education.
The learning objectives for this episode are as follows
Explain how acute grief becomes integrated over time, and how the dual process model helps us understand this adaptive process.Recognize the clinical features of Prolonged Grief Disorder, understand factors that may increase vulnerability, and distinguish it from trauma-related disorders and depression.Structure a bereavement-focused clinical history, differentiate the management of normative grief from Prolonged Grief Disorder, and approach suicide risk assessment in the context of grief.Guest: Dr. Cindy Grief
Hosts: Ahmad Khan (incoming PGY1), Dr. Angad Singh (PGY2), and Sara Abrahamson (MS3)
Audio editing: Dr. Angad Singh
Resources:
The Center for Prolonged Grief (https://prolongedgrief.columbia.edu/)Canadian Virtual Hospice (MyGrief.ca)Association for Death Education and Counseling (https://adec.org)What’s Your Grief (https://whatsyourgrief.com/)Podcasts: AllThere Is; GriefcastBooks/Memoirs:
Joan Didion, The Year of Magical ThinkingHelen Macdonald, H Is for HawkC.S. Lewis, A Grief ObservedChimamand Ngozi Adichie, Notes on GriefArticles:
A.C. Shilton, “There Is No Vaccine for Grief,” New York Times, March 2, 2021M. Stroebe, “The Poetry of Grief: Beyond Scientific Portrayal,” OMEGA: Journal of Death and Dying, 2018, 78(1), 67–96References:
Shear, K., Frank, E., Houck, P. R., & Reynolds, C. F., III. (2005). Treatment of complicated grief: A randomized controlled trial. Journal of the American Medical Association, 293(21), 2601–2608. https://doi.org/10.1001/jama.293.21.2601
Simon, N. M., & Shear, M. K. (2024). Prolonged grief disorder. New England Journal of Medicine, 391(13), 1227–1236. https://doi.org/10.1056/NEJMcp2308707
Zisook, S., & Shear, K. (2009). Grief and bereavement: What psychiatrists need to know. World Psychiatry, 8(2), 67–74. https://doi.org/10.1002/j.2051-5545.2009.tb00217.x
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers cultural concepts of distress.
The learning objectives for this episode are as follows:
Define cultural concepts of distress and describe how they are framed in DSM-5
Differentiate cultural concepts of distress from psychiatric diagnoses
Appreciate the varied clinical takeaways from cultural concepts of distress
Hosts: Sara Abrahamson (MS3), Grant Yao (MS4), Dr. Angad Singh (PGY2)
Audio editing: Dr. Angad Singh (PGY2)
References:
1. Lewis-Fernández, R., & Kirmayer, L. J. (2019). Cultural concepts of distress and psychiatric disorders: Understanding symptom experience and expression in context. Transcultural Psychiatry, 56(4), 786-803.
2. Patel, R., Ashraf, A., Myers, N., & Bhatt, N. (2025). Cultural Concepts of Distress: A Dive into Presentation and Avenues for Management. Innovations in Clinical Neuroscience, 22(7-9), 14.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Zijn er afleveringen die ontbreken?
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode is part of the PsychEd Book Club, a forum where we discuss books of interest to psychiatry learners from a variety of disciplines. We invite you to read along with us and contribute to our discussion.
This short introductory episode gives you a heads-up about our upcoming book club on How Can I Help? A Week in My Life as a Psychiatrist by David Goldbloom and Pier Bryden. Stay tuned for a longer episode in a few months where we’ll share our thoughts on the book.
If you’d like to share your thoughts or questions about the book, email us at [email protected] or reach out on social media.
Hosts:
Dr. Angad Singh, PGY2
Dr. Alastair Morrison, PGY2
Dr. Matthew Cho, PGY1
Sara Abrahamson, MS3
Dr. Sena Gok, international medical graduate and scientist
Dr. Nikhita Singhal, staff psychiatrist
Audio Editing: Dr. Matthew Cho, PGY1
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of extrapyramidal symptoms.
Hosts:
Jo Kikukawa (MS2)
Dr. Matthew Cho (PGY1)
Sena Gok (Scientist)
Audio Editing: Dr. Matthew Cho (PGY1)
References:
Dayalu, P., & Chou, K. L. (2008). Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opinion on Pharmacotherapy, 9(9), 1451–1462. https://doi.org/10.1517/14656566.9.9.1451
Drake, R. E., & Ehrlich, J. (1985).Suicide attempts associated with akathisia. American Journal of Psychiatry, 142(4), 499–501. https://doi.org/10.1176/ajp.142.4.499
Pringsheim, T., Gardner, D., Addington, D., Martino, D., Morgante, F., Ricciardi, L., Poole, N., Remington, G., Edwards, M., Carson, A., & Barnes, T. R. E. (2018). The assessment and treatment of antipsychotic-induced akathisia. Canadian Journal of Psychiatry, 63(11), 719–729. https://doi.org/10.1177/0706743718760288
Poyurovsky, M., Pashinian, A., Weizman, R., Fuchs, C., & Weizman, A. (2006). Low-dose mirtazapine: A new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biological Psychiatry, 59(11), 1071–1077. https://doi.org/10.1016/j.biopsych.2005.11.004
Links to Scales Featured in Episode:
https://simpleandpractical.com/wp-content/uploads/2014/09/Barnes-Akathisia-Rating-Scale-BARS.pdf
https://www.psychdb.com/_media/meds/antipsychotics/sas_simpson_angus_scale_modified.pdf
https://www.ohsu.edu/sites/default/files/2019-10/%28AIMS%29%20Abnormal%20Involuntary%20Movement%20Scale.pdf
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers interventional psychiatry with Dr. Sean Nestor, an interventional psychiatrist and clinician-scientist at the University of Toronto, where he serves as Assistant Director of the Psychiatry Program and oversees the Clinician Researcher Track (CResT) residency within the Department of Psychiatry. His research program at Sunnybrook Health Sciences Centre focuses on advancing the clinical application of neuromodulation therapies to improve outcomes across a wide range of psychiatric disorders.
The learning objectives for this episode are as follows
Define interventional psychiatry and distinguish it from traditional pharmacologic and psychotherapy-based approachesDescribe the role of interventional psychiatry in clinical practice, including identifying patient populations most likely to benefit from neuromodulation treatmentIdentify pathways to become involved in research and scholarly work within the field of interventional psychiatryGuest: Dr. Sean Nestor
Hosts: Dr. Pooja Sankar (PGY1), Michael Wang (MS4), Dr. Kate Braithwaite
Audio editing: Dr. Kate Braithwaite
Time Stamps:
(2:25) - Defining Interventional Psychiatry (IP) and its role in Psychiatric practice
(4:20) - Evolution of Interventional Psychiatry (IP)
(8:40) - Patients who will benefit from IP modalities
(12:35) - Other factors to consider when assessing a patient for IP
(15:30) - rTMS
(19:15) - Description of a typical rTMS session
(23:50) - ECT
(26:45) - Ketamine
(29:05) - Other Investigational Modalities
(30:45) - Maintenance treatment
(35:30) - Medication and IP
(37:55) - Addressing stigma of ECT
(43:15) - Discussion on place of IP in Depression management decision tree
(47:00) - How to get involved in IP
(50:10) - Rewarding aspects of working in IP
(52:25) - Challenges of working in IP
(53:40) - Future of the field
Resources:
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) | Stanford Health Care
CTMSS | International medical society dedicated to optimizing clinical practice, supporting research, and increasing access to high quality, evidence-based Transcranial Magnetic Stimulation
The Interventional Psychiatry Consortium
References:
Andrade, J. & Brito, M.. (2023). When the SAINT goes marching in – A novel transcranial magnetic stimulation protocol shows miraculous promise. European Psychiatry. 66. S835-S835. 10.1192/j.eurpsy.2023.1768.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults | CANMAT
Conway, C. R., & Sackeim, H. A. (2022). Interventional Psychiatry: The revolution has arrived. Brazilian Journal of Psychiatry. https://doi.org/10.47626/1516-4446-2022-0046
Rakesh, G., Cordero, P., Khanal, R., Himelhoch, S. S., & Rush, C. R. (2024). Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis. Journal of affective disorders, 358, 432–439. https://doi.org/10.1016/j.jad.2024.05.037
Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A., Jr (2022). Ketamine treatment for depression: a review. Discover mental health, 2(1), 9. https://doi.org/10.1007/s44192-022-00012-3
Zaidi, A., Shami, R., Sewell, I. J., Cao, X., Giacobbe, P., Rabin, J. S., Goubran, M., Hamani, C., Swardfager, W., Davidson, B., Lipsman, N., & Nestor, S. M. (2024). Antidepressant class and concurrent rTMS outcomes in major depressive disorder: a systematic review and meta-analysis. EClinicalMedicine, 75, 102760. https://doi.org/10.1016/j.eclinm.2024.102760
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of neuroleptic malignant syndrome.
Hosts:
Eric Yu (MS3)
Dr. Angad Singh (PGY2)
Dr. Shaoyuan Wang (PGY5)
Audio Editing:
Dr. Angad Singh (PGY2)
References:
1. Park, J., Tan, J., Krzeminski, S., Hazeghazam, M., Bandlamuri, M., & Carlson, R. W. (2017). Malignant catatonia warrants early psychiatric‐critical care collaborative management: two cases and literature review. Case Reports in Critical Care, 2017(1), 1951965.
2. Simon, L. V., Hashmi, M. F., & Callahan, A. L. (2023). Neuroleptic malignant syndrome. In StatPearls
[Internet]. StatPearls Publishing.
2. Tan, C. M., & Kumachev, A. (2023). Neuroleptic malignant syndrome. CMAJ, 195(43), E1481-E1481.
4. Trollor, J. N., & Sachdev, P. S. (1999). Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Australian & New Zealand Journal of Psychiatry, 33(5), 650-659.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers Working with Borderline Personality Disorder in the Emergency Department with Dr. Bruce Fage, a psychiatrist in Toronto working in emergency and acute care psychiatry, and an Assistant Professor at the University of Toronto. His interests include the relational and systems issues that shape psychiatric care in crisis settings. He is also a former founding member of PsychEd!
The learning objectives for this episode are as follows:
Explain how the emergency department environment influences presentations of borderline personality disorder
Know when to apply the diagnosis of borderline personality in the emergency setting
Demonstrate effective management strategies for patients with BPD in the ED
Evaluate appropriate use of emergency and inpatient care for BPD presentations
Guest:
Dr. Bruce Fage
Hosts:
Sara Abrahamson (MS3)
Shelly Palchik (MS4)
Angad Singh (PGY2)
Audio editing:
Angad Singh (PGY2)
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of serotonin syndrome.
Hosts:
Eric Yu (MS3)
Dr. Angad Singh (PGY2)
Dr. Shaoyuan Wang (PGY5)
Audio Editing:
Dr. Angad Singh (PGY2)
References:
1. Boyer, E. W. (2024). Serotonin syndrome (serotonin toxicity). In UpToDate.
2. Buckley, N. A., Dawson, A. H., & Isbister, G. K. (2014). Serotonin syndrome. Bmj, 348.
3. Dunkley, E. J. C., Isbister, G. K., Sibbritt, D., Dawson, A. H., & Whyte, I. M. (2003). The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Qjm, 96(9), 635-642.
4. Foong, A. L., Grindrod, K. A., Patel, T., & Kellar, J. (2018). Demystifying serotonin syndrome (or serotonin toxicity). Canadian Family Physician, 64(10), 720-727.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This is our second book club episode centered around the novel Healing: Our Path from Mental Illness to Mental Health by Thomas Insel, MD.
This book is a part memoir / part manifesto written by one of our generation’s most important leaders in neuroscience and psychiatry, Dr. Thomas Insel. Dr. Insel served as the director of the NIMH for 13 years from 2002-2015. Healing is replete with his reflections on personal and clinical experiences as well as epidemiological data, research, and policies related to mental health. Dr. Insel argues that medicine’s failure to significantly reduce the mortality and morbidity of psychiatric illnesses is less due to a lack of scientific progress, and more a result of poor implementation of existing interventions that are already well supported by the evidence.
Guest: Dr. Thomas Insel
Hosts: Dr. Gaurav Sharma - Staff psychiatrist working in Nunavut, Canada
Dr. Kate Braithwaite - Family doctor from South Africa
Ahmad Khan - MS4 at Western University
Dr. Sophie Gregoire-Mitha - PGY1 Psychiatry resident in Manitoba
Audio editing: Dr. Gaurav Sharma
Episode Evaluation: Dr. Angad Singh
Our discussion is divided into 3 main sections:
(2:48): Main themes from the book
(15:58): Clinical application of strategies discussed in the book
(41:30): Reflections on the book in the current Psychiatric landscape
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers harm reduction principles.
Hosts: Dr. Andrew Nguyen, Dr. Zakia Hussain, and Shelly Palchik
Audio editing: Dr. Kate Braithwaite
Episode Evaluation: Dr. Angad Singh
Resources:
Chapter 4: Substance Use and Addictive Disorders. In Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences
Serving Clients Who Use Substances: A guide for community workers
A Harm Reduction Approach (Alberta Health Services)
References:
Alberta Health Services. A Harm Reduction Approach: Key Principles.
BC Centre for Disease Control (2023). Harm Reduction Services & Supply Guidelines.
Canadian Mental Health Association Ontario. Harm Reduction.
Ontario Ministry of Health (2018). Substance Use Prevention and Harm Reduction Guideline.
NL Centre for Applied Health Research (2020). Harm Reduction 101.
Public Health Agency of Canada. Reducing Stigma Toward People Who Use Drugs.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers psychiatry and ethics in the Ontario context with Dr. Suze Berkhout, a clinician investigator and practicing psychiatrist working in acute inpatient psychiatry at University Health Network. She is an Associate Professor at the University of Toronto in the department of psychiatry and affiliate faculty with the Institute for the History & Philosophy of Science and Technology. Her research draws on critical creative methods in ethnography, art-science collaborations, and feminist science and technology studies, to consider the politics of diagnosis and social lives of interventions and emerging technologies in biomedicine. She works with artists, service users, clinicians and scientists to understand how serious illness experiences impact our sense of identity and our social roles, and she studies the impacts of novel and emerging technologies on experiences in healthcare settings. Suze loves coffee and finding new ways to think with stories.
The learning objectives are as follows:
1. Gain familiarity with key ethical concepts in psychiatry, including how ethics differs from law and the major ethical frameworks used in clinical reasoning.
2. Identify and analyze common ethical challenges in psychiatric practice, such as autonomy, confidentiality, boundaries, and justice.
3. Apply practical strategies for ethical decision-making in clinical encounters.
Guest: Dr. Suze Berkhout
Hosts: Dr. Matthew Cho (PGY1), Dr. Annie Yu (PGY4) and Sena Gok (MD)
Audio Editing: Angad Singh (PGY2)
Resources from our guest:
Bioethics for the People Podcast: https://www.bioethicsforthepeople.com/
Mimi Khúc Open in Emergency: https://www.mimikhuc.com/projects/open-in-emergency
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website atpsychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of sleep hygiene.
Hosts: Jo Kikukawa (MS2) and Grant Yao (MS4)
Audio editing: Grant Yao
Timestamps:
(0:33) - Background
(2:07) - Core principles and strategies
(5:37) - Counselling on sleep
(6:18) - When to get help with sleep
(7:29) - Summary
References:
Centre for Addiction and Mental Health. Sleep disorders. CAMH.Harvard Health Publishing. Sleep hygiene: Simple practices for better rest. Harvard Health.Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133.Sleep Foundation. Sleep hygiene. SleepFoundation.org.Spielman AJ, Caruso LS, Glovinsky PB. Behavioral treatment of insomnia: A clinical case series. Sleep. 1987;10(1):87–92.For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers Types of Substances
Hosts: Sara Abrahamson, Shaoyuan Wang and Kate Braithwaite.
Audio Editing: Kate Braithwaite
References:
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5, text revision (DSM-5-TR). 5th ed. Washington, D.C.: American Psychiatric Association Publishing; 2022.
CAMH. (2013). Inhalants. Inhalants | CAMH
CAMH. (2010). Cocaine and Crack. https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/cocaine
CAMH. (2012). Amphetamines. https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/amphetamines#:~:text=Chronic%20use%20of%20amphetamines%20can,can%20also%20cause%20amphetamine%20psychosis.
Chae J, Marsden J and Sutherland A. (2024, August 21). Benzodiazepine Withdrawal. Emergency Care BC. Benzodiazepine Withdrawal : Emergency Care BC
ChildHealthBC. (2023, September 21). Common Street names for Substances. https://childhealthbc.ca/mhsu/common_streetnames_substances/printfile
Jauch EC. (2023, January 18) Inhalants Clinical Presentation. Medscape. Inhalants Clinical Presentation: History, Physical, Causes
Kaye, AD, Staser, AN, Mccollins, TS, Zheng, J, Berry, FA, Burroughs, CR, Heisler, M, Mouhaffel, A, Ahmadzadeh, S, Kaye, AM, Shekoohi, S, & Varrassi, G. (2024). Delirium Tremens: A Review of Clinical Studies. Cureus, 16(4), e57601. https://doi.org/10.7759/cureus.57601
Long N. (2020, November 3). GHB toxicity. Life in the Fast Lane. GHB toxicity • LITFL • Toxicology Library Toxicant
Medx. (2025, November 26). Understanding What is the MOA of Alcohol: A Pharmacological Perspective. What is the MOA of Alcohol? Explained: Receptors and Effects
Mendelson, J. H., & Mello, N. K. (1996). Management of cocaine abuse and dependence. The New England journal of medicine, 334(15), 965–972. https://doi.org/10.1056/NEJM199604113341507
Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb;101(2):131-81. doi: 10.1016/j.pharmthera.2003.11.002.
Nickson C. (2024, December 18). Sedative toxidrome. Life in the Fast Lane. Sedative Toxidrome • LITFL • CCC Toxicology
Porter RS, Kaplan JL, Homeier BP, editors. The Merck manual of diagnosis and therapy. 20th ed. Kenilworth (NJ): Merck Sharp & Dohme; 2018.
PsychDB. (2021, March). Opioid Intoxication. Opioid Intoxication - PsychDB
PsychDB. (2023, October). Opioid Withdrawal. Opioid Withdrawal - PsychDB
PsychDB. (2023 February). Cannabis Withdrawal. Cannabis Withdrawal - PsychDB
Roth BL, Gumpper RH. Psychedelics as Transformative Therapeutics. Am J Psychiatry. 2023 May 1;180(5):317-20.
Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010 Sep;11(9):642-51. doi: 10.1038/nrn2884.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers the psychiatric case presentation with Dr. Justin Delwo, a staff psychiatrist at Toronto Western Hospital where he works in the emergency department and urgent care settings.
The learning objectives for this episode are as follows:
What is the goal of a psychiatric case presentation?What are some ground rules for a case presentation?What are the key sections of a case presentation and what should you include under each? How can you tailor your case presentation to the settingGuest: Dr. Justin Delwo
Hosts: Dr. Matt Cho (PGY1), Dr. Daamoon Ghahari (PGY2), and Dr. Angad Singh (PGY2)
Audio editing: Dr. Angad Singh (PGY2)
Episode evaluation: Shelly Palchik (MS4)
Time Stamps:
(1:50) - Goals of a case presentation
(4:49) - Ground rules for presenting
(7:56) - General overview
(19:44) - Identifying Data
(23:16) - Chief complaint and reason for referral
(25:42) - History of presenting illness
(38:38) - Review of systems
(42:16) - Safety
(49:42) - Past psychiatric history
(53:54) - Medications
(55:55) - Past medical history
(59:14) - Allergies
(1:00:13) - Family psychiatric history
(1:02:07) - Personal history
(1:06:23) - Mental status exam
(1:09:45) - Impression
(1:14:20) - Plan
(1:18:43) - Tailoring to different settings
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website atpsychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers how to take a substance use history
Hosts: Dr. Andrew Nguyen, Dr. Zakia Hussain, Jo Kikukawa, and Dr. Kate Braithwaite.
Audio editing: Dr. Kate Braithwaite
Resources:
Chapter 4: Substance Use and Addictive Disorders. In Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences
Meta:Phi Resource Library
Ten Domains of De-escalation to Prevent Behavioural Emergencies (from Alberta Health Services)
References:
American Psychiatric Association Publishing. (2022). Substance-Related and Addictive Disorders. In Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition, Text Revision: DSM-5-TR (5th ed., pp. 481-590). American Psychiatric Association Publishing.
Boland, R.J., Verduin, M.L., & Ruiz, P. (2022). Chapter 4: Substance Use and Addictive Disorders. In Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry (12th ed., pp. 269 - 336). Wolters Kluwer.
Porter, L.D. Getting to the Good Part: How to Take an Engaging SUD History. [Presentation Transcript]. University of California, Los Angeles Integrated Substance Use and Addictions Programs. https://www.uclaisap.org/clinicalproviderquicktips/docs/La-Donna-Porter/Porter_LD_Transcript_Clean.pdf
Welsh, C.J. “Trapped”: A Mnemonic for Taking a Substance Use History. Acad Psychiatry 27, 289 (2003). https://doi.org/10.1176/appi.ap.27.4.289
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode covers Functional Neurological Disorder with Dr. Patricia Rosebush. Dr. Rosebush is a Professor in the Department of Psychiatry & Behavioural Neurosciences at McMaster University. She is the distinguished author of numerous articles on clinical neuroscience, including considerable work on mitochondrial disorders in mental illness and over 30 papers on catatonia, and practices consultation-liaison psychiatry at St. Joseph’s Healthcare Hamilton.
The learning objectives for this episode are as follows:
Provide a definition and conceptual approach to FND
Identify clinical signs and patient histories relevant to a diagnosis of FND
Describe an approach to the treatment of FND
Understand the special challenges of communication and collaboration in this illness
Guest: Dr. Patricia Rosebush
Hosts: Dr. Alastair Morrison, Dr. Kate Braithwaite
Audio editing: Dr. Alastair Morrison
Show notes: Dr. Kate Braithwaite
Interview content:
(02:39) Learning objectives
(03:09) Conceptualization of FND
(08:30) Underlying psychological processes
(09:35) Difference between FND and factitious disorder/malingering
(14:54) Alexithymia
(16:51) Common symptomatic presentations
(18:00) Types of underlying stressors
(19:17) Other risk factors for FND
(22:12) Communicating with patients to address stigma
(24:32) Psychotherapy in FND
(29:36) Referral pathways for patients with FND
(31:15) Prognosis of FND
(33:09) Social media and FND
Resources:
Functional Neurological Disorder Society. Functional Neurological Disorder Society (FNDS). Includes a podcast and courses for physicians
Functional Neurological Disorder (FND) – A Patient's Guide to FND
References:
Hull, M., & Parnes, M. (2021). Tics and TikTok: Functional Tics Spread Through Social Media. Movement disorders clinical practice, 8(8), 1248–1252. https://doi.org/10.1002/mdc3.13267
National Institute for Neurological Disorders and Stroke. (2024, July.) Functional Neurological Disorder. U.S. Department of Health and Human Services, National Institutes of Health. Functional Neurologic Disorder | National Institute of Neurological Disorders and Stroke
PsychDB. (2024, April). Conversion Disorder (Functional Neurological Disorder. Conversion Disorder (Functional Neurological Disorder) - PsychDB
Rosebush, P. I., & Mazurek, M. F. (2011). Treatment of conversion disorder in the 21st century: have we moved beyond the couch?. Current treatment options in neurology, 13(3), 255–266. https://doi.org/10.1007/s11940-011-0124-y
Scamvougeras, A., & Castle, D. (2024). Functional Neurological Disorders: Challenging the Mainstream Agnostic Causative Position. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 69(7), 487–492. https://doi.org/10.1177/07067437241245957
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers metabolic monitoring for patients on antipsychotic medications.
Hosts: Grant Yao (MS4) and Dr. Angad Singh (PGY2)
Audio editing: Dr. Angad Singh (PGY2)
Timestamps:
(0:21) - Background
(2:22) - Monitoring for metabolic side effects
(6:16) - Managing metabolic side effects
(9:50) - Summary
References:
Agarwal, S. M., Stogios, N., Faulkner, G. E., & Hahn, M. (2023). Pharmacological interventions for the prevention of antipsychotic-induced weight gain in people with schizophrenia: A Cochrane systematic review and meta-analysis. Schizophrenia Bulletin, 49(4), 833-835.
Carolan, A., Hynes-Ryan, C., Agarwal, S. M., Bourke, R., Cullen, W., Gaughran, F., ... & O’Donoghue, B. (2024). Metformin for the prevention of antipsychotic-induced weight gain: guideline development and consensus validation. Schizophrenia bulletin, sbae205.
Cooper, S. J., Reynolds, G. P., With expert co-authors (in alphabetical order):, Barnes, T. R. E., England, E., Haddad, P. M., ... & Smith, J. (2016). BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. Journal of Psychopharmacology, 30(8), 717-748.
DeJongh, B. M. (2021). Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Mental Health Clinician, 11(6), 311-319.
Stogios, N., Humber, B., Agarwal, S. M., & Hahn, M. (2023). Antipsychotic-induced weight gain in severe mental illness: risk factors and special considerations. Current Psychiatry Reports, 25(11), 707-721.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.
This episode is part of the PsychEd Book Club, a forum where we discuss books of interest to psychiatry learners from a variety of disciplines. We invite you to read along with us and contribute to our discussion.
This short introductory episode gives you a heads-up about our upcoming book club on Healing: Our Path from Mental Illness to Mental Health by Thomas Insel. Stay tuned for a longer episode in a few months where we’ll share our thoughts on the book.
If you’d like to share your thoughts or questions about the book, email us at [email protected] or reach out on social media.
Hosts: Dr. Kate Braithwaite, Dr. Sophie Gregoire-Mitha, Dr. Gaurav Sharma
Audio editing by: Dr. Gaurav Sharma
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers goals of care conversations.
Our guest for this episode is Dr. Tavis Apramian, a clinician-investigator in the Department of Family & Community Medicine (DFCM) at the University of Toronto and scientist in the Office of Education Scholarship. He works as a palliative care physician at St. Michael’s Hospital and at Kensington Hospice. His largely qualitative program of research is focused on advance care planning; workplace-based learning and assessment; palliative care in family medicine; medical assistance in dying; and inequity in end-of-life care. His primary focus is on telling rich stories of learner and patient experiences to spark conversation about socioculturally complex educational and clinical problems in serious illness.
The learning objectives for this episode are as follows:
Describe a palliative approach to care and its relevance across different contexts
Demonstrate a structured and compassionate approach to goals of care conversations
Apply effective communication strategies to build therapeutic alliance, navigate difficult conversations, and involve multiple actors in the palliative context
Recognize and manage challenges in goals of care conversations
Guest: Dr. Tavis Apramian
Hosts: Dr. Daamoon Ghahari (PGY2) and Dr. Angad Singh (PGY2)
Audio editing: Dr. Angad Singh (PGY2)
Timestamps:
(1:07) - Journey to palliative care
(5:07) - What is palliative care
(14:47) - Understanding patient values
(33:47) - Structuring goals of care conversations
(44:16) - Communication strategies
(57:05) - Navigating family meetings
(77:25) - Reflections on MAiD for sole mental illness
Resources:
Roth, H. (2024). Hearing the unspoken. Canadian Family Physician, 70(10), 642-642. https://pmc.ncbi.nlm.nih.gov/articles/PMC11477260/pdf/0700642.pdf
References:
Bernacki, R. E., & Block, S. D. (2014). Communication about serious illness care goals: a review and synthesis of best practices. JAMA internal medicine, 174(12), 1994-2003.
Gross, J., & Koffman, J. (2024). Examining how goals of care communication are conducted between doctors and patients with severe acute illness in hospital settings: A realist systematic review. PLoS One, 19(3), e0299933.
Scheunemann, L. P., Ernecoff, N. C., Buddadhumaruk, P., Carson, S. S., Hough, C. L., Curtis, J. R., ... & White, D. B. (2019). Clinician-family communication about patients’ values and preferences in intensive care units. JAMA internal medicine, 179(5), 676-684.
You, J. J., Downar, J., Fowler, R. A., Lamontagne, F., Ma, I. W., Jayaraman, D., ... & Canadian Researchers at the End of Life Network (CARENET). (2015). Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians. JAMA Internal Medicine, 175(4), 549-556.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
-
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of electroconvulsive therapy.
Hosts: Ravi Bhindi (CC3), Dr. Angad Singh (PGY2)
Audio Editing: Dr. Angad Singh (PGY2)
Show Notes: Dr. Angad Singh (PGY2)
Time Stamps:
(0:36) - What is ECT?
(2:18) - Indications and efficacy
(4:35) - Treatment course
(4:32) - Combination treatment
(6:33) - Medications to discontinue
(8:16) - Contraindications
(9:40) - Side effects
(11:52) - Procedure
(16:03) - Summary
Resources:
https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/electroconvulsive-therapyhttps://sunnybrook.ca/content/?page=psychiatry-electroconvulsive-therapy-ect-faqReferences:
Andrade, C., Arumugham, S. S., & Thirthalli, J. (2016). Adverse Effects of Electroconvulsive Therapy. The Psychiatric clinics of North America, 39(3), 513–530.
Brakemeier, E. L., Merkl, A., Wilbertz, G., Quante, A., Regen, F., Bührsch, N., van Hall, F., Kischkel, E., Danker-Hopfe, H., Anghelescu, I., Heuser, I., Kathmann, N., & Bajbouj, M. (2014). Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biological psychiatry, 76(3), 194–202.
Espinoza, R. T., & Kellner, C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667-672.
Gill, S., Hussain, S., Purushothaman, S., Sarma, S., Weiss, A., Chamoli, S., ... & Loo, C. K. (2023). Prescribing electroconvulsive therapy for depression: Not as simple as it used to be. Australian & New Zealand Journal of Psychiatry, 57(9), 1202-1207.
Janjua, A. U., Dhingra, A. L., Greenberg, R., & McDonald, W. M. (2020). The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy (ECT). CNS Drugs, 34(5), 509-520.
Jelovac, A., Kolshus, E., & McLoughlin, D. M. (2013). Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38(12), 2467–2474.
Kolshus, E., Jelovac, A., & McLoughlin, D. M. (2017). Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials. Psychological Medicine, 47(3), 518-530.
Lam, R. W., Kennedy, S. H., Adams, C., Bahji, A., Beaulieu, S., Bhat, V., ... & Milev, R. V. (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry, 69(9), 641-687.
Luchini, F., Medda, P., Mariani, M. G., Mauri, M., Toni, C., & Perugi, G. (2015). Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World journal of psychiatry, 5(2), 182–192.
Tess, A. V., & Smetana, G. W. (2009). Medical evaluation of patients undergoing electroconvulsive therapy. New England Journal of Medicine, 360(14), 1437-1444.
Zolezzi M. (2016). Medication management during electroconvulsant therapy. Neuropsychiatric disease and treatment, 12, 931–939.
For more PsychEd, follow us on Instagram (@psyched.podcast), Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social). You can email us at [email protected] and visit our website at psychedpodcast.org.
- Laat meer zien
